Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer
by on Tuesday, August 7th, 2012 | No Comments
Condition: Locally Recurrent or Metastatic Breast Cancer
Interventions: Drug: Docetaxel; Drug: Nintedanib
Sponsors: Centre Oscar Lambret; Centre Oscar Lambret
Not yet recruiting – verified August 2012
Follow this link: Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer